Merck & Co. Inc. (MRK): Price and Financial Metrics

MRK POWR Grades

• MRK scores best on the Growth dimension, with a Growth rank ahead of 93.04% of US stocks.
• The strongest trend for MRK is in Growth, which has been heading up over the past 179 days.
• MRK ranks lowest in Momentum; there it ranks in the 8th percentile.

MRK Stock Summary

• MRK has a higher market value than 98.94% of US stocks; more precisely, its current market capitalization is $206,187,230,241.
• MRK's went public 36.27 years ago, making it older than 92.84% of listed US stocks we're tracking.
• In terms of volatility of its share price, MRK is more volatile than only 7.11% of stocks we're observing.
• Stocks with similar financial metrics, market capitalization, and price volatility to Merck & Co Inc are TXN, INTC, NVS, BMY, and LLY.
• MRK's SEC filings can be seen here. And to visit Merck & Co Inc's official web site, go to www.merck.com.

MRK Valuation Summary

• MRK's price/earnings ratio is 34.7; this is 4.93% lower than that of the median Healthcare stock.
• Over the past 243 months, MRK's price/sales ratio has gone up 0.7.
• Over the past 243 months, MRK's price/sales ratio has gone up 0.7.

Below are key valuation metrics over time for MRK.

MRK Growth Metrics

Its 5 year net income to common stockholders growth rate is now at 119.85%.
• Its 4 year net income to common stockholders growth rate is now at 119.85%.
• Its 5 year price growth rate is now at 42.55%.

MRK's revenue has moved up $1,356,000,000 over the prior 15 months.

The table below shows MRK's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	48,704	14,109	13,049
2021-09-30	49,151	13,084	7,197
2021-06-30	48,548	10,460	5,571
2021-03-31	48,018	11,337	7,028
2020-12-31	47,994	10,253	7,067
2020-09-30	47,348	11,041	11,518

MRK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• MRK has a Quality Grade of B, ranking ahead of 77.57% of graded US stocks.
• MRK's asset turnover comes in at 0.535 -- ranking 75th of 682 Pharmaceutical Products stocks.
• XTNT, ACOR, and BDSI are the stocks whose asset turnover ratios are most correlated with MRK.

The table below shows MRK's key quality metrics over time.